Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

Now Is the Time to Implement Whole Genome Sequencing in the Global Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae?

Golparian D, Unemo M.

EClinicalMedicine. 2019 Feb 18;7:11-12. doi: 10.1016/j.eclinm.2019.02.002. eCollection 2019 Jan. No abstract available.

2.

Prediction of Minimum Inhibitory Concentrations of Antimicrobials for Neisseria gonorrhoeae Using Whole-Genome Sequencing.

Eyre DW, Golparian D, Unemo M.

Methods Mol Biol. 2019;1997:59-76. doi: 10.1007/978-1-4939-9496-0_4.

PMID:
31119617
3.

Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.

Unemo M, Golparian D, Eyre DW.

Methods Mol Biol. 2019;1997:37-58. doi: 10.1007/978-1-4939-9496-0_3.

PMID:
31119616
4.

In vitro activity of the ketolide cethromycin in multidrug-resistant clinical Neisseria gonorrhoeae isolates and international reference strains.

Jacobsson S, Alirol E, Unemo M.

J Chemother. 2019 May 20:1-6. doi: 10.1080/1120009X.2019.1615724. [Epub ahead of print]

PMID:
31106713
5.

Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates.

Lee K, Nakayama SI, Osawa K, Yoshida H, Arakawa S, Furubayashi KI, Kameoka H, Shimuta K, Kawahata T, Unemo M, Ohnishi M.

J Antimicrob Chemother. 2019 Apr 19. pii: dkz129. doi: 10.1093/jac/dkz129. [Epub ahead of print]

PMID:
31002306
6.

Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis.

Kenyon C, Buyze J, Spiteri G, Cole MJ, Unemo M.

J Infect Dis. 2019 Apr 8. pii: jiz153. doi: 10.1093/infdis/jiz153. [Epub ahead of print]

PMID:
30957153
7.

Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data.

Cole MJ, Quaye N, Jacobsson S, Day M, Fagan E, Ison C, Pitt R, Seaton S, Woodford N, Stary A, Pleininger S, Crucitti T, Hunjak B, Maikanti P, Hoffmann S, Viktorova J, Buder S, Kohl P, Tzelepi E, Siatravani E, Balla E, Hauksdóttir GS, Rose L, Stefanelli P, Carannante A, Pakarna G, Mifsud F, Cassar RZ, Linde I, Bergheim T, Steinbakk M, Mlynarczyk-Bonikowska B, Borrego MJ, Shepherd J, Pavlik P, Jeverica S, Vazquez J, Abad R, Weiss S, Spiteri G, Unemo M.

BMC Infect Dis. 2019 Mar 25;19(1):281. doi: 10.1186/s12879-019-3900-z.

8.

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.

Boiko I, Golparian D, Krynytska I, Bezkorovaina H, Frankenberg A, Onuchyna M, Jacobsson S, Unemo M.

APMIS. 2019 Jul;127(7):503-509. doi: 10.1111/apm.12948. Epub 2019 May 21.

PMID:
30903707
9.

Collecting and exploiting data to understand a nation's sexual health needs: Implications for the British National Surveys of Sexual Attitudes and Lifestyles (Natsal).

Mercer CH, Clifton S, Prior G, Aldridge RW, Bonell C, Copas AJ, Field N, Gibbs J, Macdowall W, Mitchell KR, Tanton C, Thomson N, Unemo M, Sonnenberg P.

Sex Transm Infect. 2019 May;95(3):159-161. doi: 10.1136/sextrans-2018-053571. Epub 2019 Mar 19. No abstract available. Erratum in: Sex Transm Infect. 2019 May 28;:.

10.

The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe.

Spiteri G, Unemo M, Mårdh O, Amato-Gauci AJ.

Epidemiol Infect. 2019 Jan;147:e143. doi: 10.1017/S0950268819000281.

11.

Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16.

Gianecini RA, Golparian D, Zittermann S, Litvik A, Gonzalez S, Oviedo C, Melano RG, Unemo M, Galarza P; Gonococcal Antimicrobial Susceptibility Surveillance Programme-Argentina (GASSP-AR) Working Group .

J Antimicrob Chemother. 2019 Jun 1;74(6):1551-1559. doi: 10.1093/jac/dkz054.

PMID:
30820563
12.

Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012-2017.

Lee H, Suh YH, Lee S, Kim YK, Han MS, Bae HG, Unemo M, Lee K.

Emerg Infect Dis. 2019 Mar;25(3):416-424. doi: 10.3201/eid2503.181503.

13.

In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?

Jacobsson S, Mason C, Khan N, Meo P, Unemo M.

J Antimicrob Chemother. 2019 Jun 1;74(6):1591-1594. doi: 10.1093/jac/dkz060.

14.

Quantitation of all Four Gardnerella vaginalis Clades Detects Abnormal Vaginal Microbiota Characteristic of Bacterial Vaginosis More Accurately than Putative G. vaginalis Sialidase A Gene Count.

Shipitsyna E, Krysanova A, Khayrullina G, Shalepo K, Savicheva A, Guschin A, Unemo M.

Mol Diagn Ther. 2019 Feb;23(1):139-147. doi: 10.1007/s40291-019-00382-5.

15.
16.

Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review.

Kong FYS, Horner P, Unemo M, Hocking JS.

J Antimicrob Chemother. 2019 Jan 11. doi: 10.1093/jac/dky548. [Epub ahead of print]

PMID:
30649333
17.

Pharmacokinetic Data Are Predictive of In Vivo Efficacy for Cefixime and Ceftriaxone against Susceptible and Resistant Neisseria gonorrhoeae Strains in the Gonorrhea Mouse Model.

Connolly KL, Eakin AE, Gomez C, Osborn BL, Unemo M, Jerse AE.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01644-18. doi: 10.1128/AAC.01644-18. Print 2019 Mar.

PMID:
30642924
18.

Antibiotic resistance and NG-MAST sequence types of Neisseria gonorrhoeae isolates in Poland compared to the world.

Mlynarczyk-Bonikowska B, Malejczyk M, Majewski S, Unemo M.

Postepy Dermatol Alergol. 2018 Dec;35(6):346-551. doi: 10.5114/ada.2018.79780. Epub 2018 Nov 26. Review.

19.

Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencer.

Golparian D, Donà V, Sánchez-Busó L, Foerster S, Harris S, Endimiani A, Low N, Unemo M.

Sci Rep. 2018 Dec 4;8(1):17596. doi: 10.1038/s41598-018-35750-4.

20.

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.

Day MJ, Spiteri G, Jacobsson S, Woodford N, Amato-Gauci AJ, Cole MJ, Unemo M; Euro-GASP network.

BMC Infect Dis. 2018 Dec 3;18(1):609. doi: 10.1186/s12879-018-3528-4.

21.

Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018.

Golparian D, Rose L, Lynam A, Mohamed A, Bercot B, Ohnishi M, Crowley B, Unemo M.

Euro Surveill. 2018 Nov;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.1800617.

22.

Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014-2017.

Yéo A, Kouamé-Blavo B, Kouamé CE, Ouattara A, Yao AC, Gbedé BD, Bazan F, Faye-Ketté H, Dosso M, Wi T, Unemo M.

Sex Transm Dis. 2019 Mar;46(3):179-184. doi: 10.1097/OLQ.0000000000000943.

PMID:
30461598
23.

WHO laboratory validation of Xpert® CT/NG and Xpert® TV on the GeneXpert system verifies high performances.

Jacobsson S, Boiko I, Golparian D, Blondeel K, Kiarie J, Toskin I, Peeling RW, Unemo M.

APMIS. 2018 Dec;126(12):907-912. doi: 10.1111/apm.12902.

24.

Lymphogranuloma venereum (LGV) in men who have sex with men (MSM): a re-emerging problem, Malta, 2018.

Donachie A, Spiteri G, Barbara C, Melillo T, Hadad R, Gauci Farrugia A, Unemo M, Padovese V.

Euro Surveill. 2018 Oct;23(43). doi: 10.2807/1560-7917.ES.2018.23.43.1800541.

25.

Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.

El-Rami FE, Zielke RA, Wi T, Sikora AE, Unemo M.

Mol Cell Proteomics. 2019 Jan;18(1):127-150. doi: 10.1074/mcp.RA118.001125. Epub 2018 Oct 23.

PMID:
30352803
26.

Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Yaoundé, Cameroon From 2009 to 2014.

Tayimetha CY, Unemo M.

Sex Transm Dis. 2018 Dec;45(12):e101-e103. doi: 10.1097/OLQ.0000000000000915.

PMID:
30234796
27.

Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae.

Jönsson A, Jacobsson S, Foerster S, Cole MJ, Unemo M.

APMIS. 2018 Oct;126(10):822-827. doi: 10.1111/apm.12887. Epub 2018 Sep 6.

PMID:
30191618
28.

Aptima Trichomonas vaginalis assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study.

Bruni MP, Freitas da Silveira M, Stauffert D, Bicca GLO, Caetano Dos Santos C, da Rosa Farias NA, Golparian D, Unemo M.

Sex Transm Infect. 2019 Mar;95(2):129-132. doi: 10.1136/sextrans-2018-053635. Epub 2018 Aug 28.

PMID:
30154157
29.

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018.

Eyre DW, Sanderson ND, Lord E, Regisford-Reimmer N, Chau K, Barker L, Morgan M, Newnham R, Golparian D, Unemo M, Crook DW, Peto TE, Hughes G, Cole MJ, Fifer H, Edwards A, Andersson MI.

Euro Surveill. 2018 Jul;23(27). doi: 10.2807/1560-7917.ES.2018.23.27.1800323.

30.

Advancing the public health applications of Chlamydia trachomatis serology.

Woodhall SC, Gorwitz RJ, Migchelsen SJ, Gottlieb SL, Horner PJ, Geisler WM, Winstanley C, Hufnagel K, Waterboer T, Martin DL, Huston WM, Gaydos CA, Deal C, Unemo M, Dunbar JK, Bernstein K.

Lancet Infect Dis. 2018 Dec;18(12):e399-e407. doi: 10.1016/S1473-3099(18)30159-2. Epub 2018 Jul 5. Review.

PMID:
29983342
31.

Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens.

Donà V, Smid JH, Kasraian S, Egli-Gany D, Dost F, Imeri F, Unemo M, Low N, Endimiani A.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00365-18. doi: 10.1128/JCM.00365-18. Print 2018 Sep.

32.

Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board.

Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1845-1851. doi: 10.1111/jdv.15146. Epub 2018 Jul 6. Review.

PMID:
29924422
33.

Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.

Ryan L, Golparian D, Fennelly N, Rose L, Walsh P, Lawlor B, Mac Aogáin M, Unemo M, Crowley B.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1661-1672. doi: 10.1007/s10096-018-3296-5. Epub 2018 Jun 7.

PMID:
29882175
34.

Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017.

Poncin T, Fouere S, Braille A, Camelena F, Agsous M, Bebear C, Kumanski S, Lot F, Mercier-Delarue S, Ngangro NN, Salmona M, Schnepf N, Timsit J, Unemo M, Bercot B.

Euro Surveill. 2018 May;23(21). doi: 10.2807/1560-7917.ES.2018.23.21.1800264.

35.

In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae.

Jacobsson S, Golparian D, Scangarella-Oman N, Unemo M.

J Antimicrob Chemother. 2018 Aug 1;73(8):2072-2077. doi: 10.1093/jac/dky162.

PMID:
29796611
36.

Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey.

Harris SR, Cole MJ, Spiteri G, Sánchez-Busó L, Golparian D, Jacobsson S, Goater R, Abudahab K, Yeats CA, Bercot B, Borrego MJ, Crowley B, Stefanelli P, Tripodo F, Abad R, Aanensen DM, Unemo M; Euro-GASP study group.

Lancet Infect Dis. 2018 Jul;18(7):758-768. doi: 10.1016/S1473-3099(18)30225-1. Epub 2018 May 15.

37.
38.

First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.

Bazzo ML, Golfetto L, Gaspar PC, Pires AF, Ramos MC, Franchini M, Ferreira WA, Unemo M, Benzaken AS; Brazilian-GASP Network .

J Antimicrob Chemother. 2018 Jul 1;73(7):1854-1861. doi: 10.1093/jac/dky090.

PMID:
29635367
39.

In Vivo-Selected Compensatory Mutations Restore the Fitness Cost of Mosaic penA Alleles That Confer Ceftriaxone Resistance in Neisseria gonorrhoeae.

Vincent LR, Kerr SR, Tan Y, Tomberg J, Raterman EL, Dunning Hotopp JC, Unemo M, Nicholas RA, Jerse AE.

MBio. 2018 Apr 3;9(2). pii: e01905-17. doi: 10.1128/mBio.01905-17.

40.

Dual antimicrobial therapy for gonorrhoea: what is the role of azithromycin?

Unemo M, Workowski K.

Lancet Infect Dis. 2018 May;18(5):486-488. doi: 10.1016/S1473-3099(18)30162-2. Epub 2018 Mar 6. No abstract available.

PMID:
29523498
41.

In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains.

Damião Gouveia AC, Unemo M, Jensen JS.

J Antimicrob Chemother. 2018 May 1;73(5):1291-1294. doi: 10.1093/jac/dky022.

PMID:
29444242
42.

Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating penA Sequences in Neisseria gonorrhoeae.

Igawa G, Yamagishi Y, Lee KI, Dorin M, Shimuta K, Suematsu H, Nakayama SI, Mikamo H, Unemo M, Ohnishi M.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02069-17. doi: 10.1128/AAC.02069-17. Print 2018 Mar.

43.

Mycoplasma genitalium: whole genome sequence analysis, recombination and population structure.

Fookes MC, Hadfield J, Harris S, Parmar S, Unemo M, Jensen JS, Thomson NR.

BMC Genomics. 2017 Dec 28;18(1):993. doi: 10.1186/s12864-017-4399-6.

44.

Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015.

Hadad R, Golparian D, Lagos AC, Ljungberg J, Nilsson P, Jensen JS, Fredlund H, Unemo M.

APMIS. 2018 Feb;126(2):123-127. doi: 10.1111/apm.12792. Epub 2017 Dec 13.

PMID:
29235145
45.

Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections.

Kelly H, Coltart CEM, Pant Pai N, Klausner JD, Unemo M, Toskin I, Peeling RW.

Sex Transm Infect. 2017 Dec;93(S4):S22-S30. doi: 10.1136/sextrans-2016-053067. Review.

46.

Performance and operational characteristics of point-of-care tests for the diagnosis of urogenital gonococcal infections.

Guy RJ, Causer LM, Klausner JD, Unemo M, Toskin I, Azzini AM, Peeling RW.

Sex Transm Infect. 2017 Dec;93(S4):S16-S21. doi: 10.1136/sextrans-2017-053192. Review.

47.

In vitro activity and time-kill curve analysis of sitafloxacin against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae isolates.

Jönsson A, Foerster S, Golparian D, Hamasuna R, Jacobsson S, Lindberg M, Jensen JS, Ohnishi M, Unemo M.

APMIS. 2018 Jan;126(1):29-37. doi: 10.1111/apm.12777. Epub 2017 Nov 20.

PMID:
29154480
48.

Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed.

Unemo M, Althaus CL.

PLoS Med. 2017 Oct 31;14(10):e1002423. doi: 10.1371/journal.pmed.1002423. eCollection 2017 Oct.

49.

Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017.

Terkelsen D, Tolstrup J, Johnsen CH, Lund O, Larsen HK, Worning P, Unemo M, Westh H.

Euro Surveill. 2017 Oct;22(42). doi: 10.2807/1560-7917.ES.2017.22.42.17-00659.

50.

Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice.

Donders GGG, Ravel J, Vitali B, Netea MG, Salumets A, Unemo M.

Gynecol Obstet Invest. 2017;82(6):607-616. doi: 10.1159/000478982. Epub 2017 Oct 10.

PMID:
29017160

Supplemental Content

Support Center